All Stories

  1. Disparities, Perceived Discrimination, and Patient-Clinician Communication in Alcohol Use Disorder Treatment: An All of Us Cohort Study
  2. Impact of mental health first aid training in California pharmacy professionals
  3. Effects of Peer-to-Peer Opioid Overdose and Naloxone Training in Adolescents
  4. Psychiatric pharmacists improve patient access to quality healthcare
  5. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states
  6. Pharmacy students' perceptions of the effectiveness of a film-based mental health elective course
  7. Pharmacist furnishing of naloxone in California: A follow-up analysis
  8. Provision of Naloxone Without a Prescription by California Pharmacists 2 Years After Legislation Implementation
  9. Chapter 28: Psychiatric Patients
  10. Book Review: Clinical handbook of psychotropic drugs, 19th revised edition
  11. Central Nervous System Adverse Effects with Efavirenz: Case Report and Review
  12. Liquid Risperidone in the Treatment of Psychotic Agitation
  13. Ecstasy: Dangers and Controversies
  14. Book Review: Comprehensive Care of Schizophrenia: A Textbook of Clinical Management
  15. Comprehensive Care of Schizophrenia: A Textbook of Clinical Management
  16. Psychiatric Pharmacists
  17. Prediction of Valproate Serum Concentrations in Adult Psychiatric Patients Using Bayesian Model Estimations With NPEM2 Population Pharmacokinetic Parameters
  18. Does the Addition of Pindolol Accelerate or Enhance the Response to Selective Serotonin Reuptake Inhibitor Antidepressants?
  19. Mirtazapine, an antidepressant
  20. Drs. Puzantian and Shaw Reply
  21. Nefazodone and Neurotoxicity
  22. Nefazodone and Symptoms Suggesting Neurotoxicity
  23. Criteria for use of valproate in adult psychiatric inpatients and outpatients